ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Excerpts From Potti’s Application to Practice Medicine In South Carolina

December 9, 2011

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984